Vaughan Nelson Investment Management, L.P. Maravai Lifesciences Holdings, Inc. Transaction History

Vaughan Nelson Investment Management, L.P.

$11.2 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$12.99 - $16.48 $291,625 - $369,976	-22,450 Reduced 1.79%	1,232,360 $17.3 Million
Q4 2022 Jan 30, 2023	SELL	$12.5 - $24.78 $114,250 - $226,489	-9,140 Reduced 0.72%	1,254,810 $18 Million
Q3 2022 Nov 04, 2022	BUY	$20.6 - $30.37 $5.7 Million - $8.41 Million	276,930 Added 28.06%	1,263,950 $32.3 Million
Q2 2022 Jul 22, 2022	BUY	$26.05 - $37.48 $9.62 Million - $13.8 Million	369,335 Added 59.79%	987,020 $28 Million
Q1 2022 May 04, 2022	BUY	$24.46 - $40.92 $15.1 Million - $25.3 Million	617,685 New	617,685 $21.8 Million

Others Institutions Holding MRVI

# of Institutions

234

Shares Held

140M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $738M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.

Account